Buy CryptoMarketsSpotFuturesGOLDEarnEvent Centre
More
The post Record Crypto Derivatives Volume by CME Group appeared on BitcoinEthereumNews.com. Key Points: CME Group reports new peak in crypto derivatives trading volume. Strong institutional interest fuels trading activity. Ethereum futures see notable trading surge. CME Group’s latest report reveals a record-high average daily trading volume of 340,000 cryptocurrency contracts in Q3 2023, highlighting significant institutional interest in crypto derivatives. These volumes underscore the growing role of regulated derivatives markets in shaping institutional strategies, influencing liquidity, and possibly affecting the broader crypto market dynamics. CME’s Crypto Derivatives Skyrocket with 340,000 Daily Contracts CME Group reported an average daily trading volume of 340,000 cryptocurrency contracts in Q3 with Ethereum futures leading growth. The trading volume increase indicates heightened institutional interest in crypto derivatives. September’s average daily volume stood at 309,000 contracts, as CME aims to strengthen its position in the crypto sector. According to Tim McCourt, “client demand for around-the-clock cryptocurrency trading has grown.” This statement signals CME’s commitment to meeting market demands for seamless trading opportunities across different time zones. Institutional and larger market participants seem to leverage CME’s regulated platforms, enhancing market confidence in the stability and security offered in these trading instruments. Ethereum (ETH) trades at $4,471.83, with a market cap nearing $539.76 billion and dominating 13.07% of the market. CoinMarketCap data shows a 24-hour trading volume at $46.48 billion. ETH price rose 1.77% in the past day, 13.26% over a week, and 78.00% in the last 90 days. Insights from Coincu research team suggest continued institutional preference for regulated trading venues, driven by regulatory clarity. Historical trends show CME Group’s crypto futures volumes also soar during periods of financial turbulence, ETF launches, and major market rallies. Ethereum Futures Surge Amid Institutional Trading Growth Did you know? The 472% increase in micro Ethereum futures trading in September shows the substantial impact of institutional demand in regulated markets. Ethereum (ETH)… The post Record Crypto Derivatives Volume by CME Group appeared on BitcoinEthereumNews.com. Key Points: CME Group reports new peak in crypto derivatives trading volume. Strong institutional interest fuels trading activity. Ethereum futures see notable trading surge. CME Group’s latest report reveals a record-high average daily trading volume of 340,000 cryptocurrency contracts in Q3 2023, highlighting significant institutional interest in crypto derivatives. These volumes underscore the growing role of regulated derivatives markets in shaping institutional strategies, influencing liquidity, and possibly affecting the broader crypto market dynamics. CME’s Crypto Derivatives Skyrocket with 340,000 Daily Contracts CME Group reported an average daily trading volume of 340,000 cryptocurrency contracts in Q3 with Ethereum futures leading growth. The trading volume increase indicates heightened institutional interest in crypto derivatives. September’s average daily volume stood at 309,000 contracts, as CME aims to strengthen its position in the crypto sector. According to Tim McCourt, “client demand for around-the-clock cryptocurrency trading has grown.” This statement signals CME’s commitment to meeting market demands for seamless trading opportunities across different time zones. Institutional and larger market participants seem to leverage CME’s regulated platforms, enhancing market confidence in the stability and security offered in these trading instruments. Ethereum (ETH) trades at $4,471.83, with a market cap nearing $539.76 billion and dominating 13.07% of the market. CoinMarketCap data shows a 24-hour trading volume at $46.48 billion. ETH price rose 1.77% in the past day, 13.26% over a week, and 78.00% in the last 90 days. Insights from Coincu research team suggest continued institutional preference for regulated trading venues, driven by regulatory clarity. Historical trends show CME Group’s crypto futures volumes also soar during periods of financial turbulence, ETF launches, and major market rallies. Ethereum Futures Surge Amid Institutional Trading Growth Did you know? The 472% increase in micro Ethereum futures trading in September shows the substantial impact of institutional demand in regulated markets. Ethereum (ETH)…

Record Crypto Derivatives Volume by CME Group

Author: BitcoinEthereumNews
Source: BitcoinEthereumNews
2025/10/03 10:01
2 min read
ETH
ETH$1,987.02-3.45%
4
4$0.008075-4.93%
CAP
CAP$0.10111+0.97%
ROSE
ROSE$0.01161-3.08%
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Key Points:
  • CME Group reports new peak in crypto derivatives trading volume.
  • Strong institutional interest fuels trading activity.
  • Ethereum futures see notable trading surge.

CME Group’s latest report reveals a record-high average daily trading volume of 340,000 cryptocurrency contracts in Q3 2023, highlighting significant institutional interest in crypto derivatives.

These volumes underscore the growing role of regulated derivatives markets in shaping institutional strategies, influencing liquidity, and possibly affecting the broader crypto market dynamics.

CME’s Crypto Derivatives Skyrocket with 340,000 Daily Contracts

CME Group reported an average daily trading volume of 340,000 cryptocurrency contracts in Q3 with Ethereum futures leading growth. The trading volume increase indicates heightened institutional interest in crypto derivatives. September’s average daily volume stood at 309,000 contracts, as CME aims to strengthen its position in the crypto sector. According to Tim McCourt, “client demand for around-the-clock cryptocurrency trading has grown.” This statement signals CME’s commitment to meeting market demands for seamless trading opportunities across different time zones. Institutional and larger market participants seem to leverage CME’s regulated platforms, enhancing market confidence in the stability and security offered in these trading instruments.

Ethereum (ETH) trades at $4,471.83, with a market cap nearing $539.76 billion and dominating 13.07% of the market. CoinMarketCap data shows a 24-hour trading volume at $46.48 billion. ETH price rose 1.77% in the past day, 13.26% over a week, and 78.00% in the last 90 days.

Insights from Coincu research team suggest continued institutional preference for regulated trading venues, driven by regulatory clarity. Historical trends show CME Group’s crypto futures volumes also soar during periods of financial turbulence, ETF launches, and major market rallies.

Ethereum Futures Surge Amid Institutional Trading Growth

Did you know? The 472% increase in micro Ethereum futures trading in September shows the substantial impact of institutional demand in regulated markets.

Ethereum (ETH) trades at $4,471.83, with a market cap nearing $539.76 billion and dominating 13.07% of the market. CoinMarketCap data shows a 24-hour trading volume at $46.48 billion.

Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 01:55 UTC on October 3, 2025. Source: CoinMarketCap

Insights from Coincu research team suggest continued institutional preference for regulated trading venues, driven by regulatory clarity.

DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.

Source: https://coincu.com/news/cme-group-record-crypto-volume/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09